Key result
Survey assesses primary care physician attitudes and barriers regarding blood biomarkers for Alzheimer's disease diagnosis.
Barriers may delay blood biomarker adoption in primary care Alzheimer's diagnosis; leaves open strategies to address physician concerns and resource gaps.
To uncover primary care physicians’ (PCPs’) attitudes on, perceptions of and barriers to Alzheimer’s disease (AD) diagnosis and incorporating blood biomarkers (BBMs) into the diagnostic workflow.
No takes yet. Share an insight, caveat, or question.
Alford et al. (2026) studied this question. Primary care physician attitudes, perceptions, and barriers regarding the incorporation of blood biomarkers into Alzheimer's disease diagnostic workflows were evaluated in the USA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: